The Zingiber Officinale Roscoe Combat Helicobacter Pylori Infection in Human Gastrointestinal Tract Diagnosis and Treatment
Zingiber officinale Roscoe to Combat H. Pylori Infection
DOI:
https://doi.org/10.54393/pjhs.v3i05.192Keywords:
H. Pylori Bacteria, Ginger, Management, Identification, StomachAbstract
Twenty years after the initial culture of HP, there has been a substantial change in the finding and treatment of upper gastroduodenal disease. A growing number of stomach cancers are caused by Helicobacter pylori infection, and researchers are also looking into how this infection affects other upper gastric tract inflammation. There has been significant progress in our understanding of the pathogenesis of this infection. Although there are powerful anti-microbial medications on the market, there is still no perfect treatment and the therapeutic indications are constantly evolving. Following the discovery of an HP infection, the clinician assesses the patient's clinical condition to determine whether therapy is necessary. Typically, HP eradication is suggested for the treatment and prevention of the infection. The microorganism that is introduced into the human stomach cancer that develops in the gastrointestinal tract causes the HP disease. In addition to gastrointestinal issues like belching, bloating, vomiting, indigestion, and constipation, it has been used for a long time to treat a variety of disorders. The purpose of the current study's findings was to assess how supplementing with ginger powder affected patients who had the HP infection's eradication and the relief of their dyspeptic symptoms.
References
Alfarouk KO, Adil HH, Ahmed NA, AbdelRahman MR, Abdel KM, Sari TS, et al. Helicobacter pylori the possible role of in gastric cancer and its management. Frontiers in Oncology. 2019; 9:75.
Centers for Disease Control and Prevention (CDC. CDC Yellow Book 2020: health information for international travel. Oxford University Press; 2019 May.
Yamaoka Y, editor. Helicobacter pylori: molecular genetics and cellular biology. Horizon Scientific Press; 2008.
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiologic reviews. 2000 Jan; 22(2):283-97.
Marshall C, Baller J, Stokes S. COMMENTS OF.
Pooja V, Susmitha K, Venkatesh P, Kalarini DH, Prema R. A Literature Review on Helicobacter Pylori Management.
Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford). 2019 Mar; 60(8):3513–21. doi: 10.1093/rheumatology/kez052
Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO reports. 2006 Aug; 7(10):956-60.
Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. Postgraduate Medical Journal. 2016 Aug; 92(1090):471-7. doi: 10.1136/postgradmedj-2016-133997
Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects. World Journal of Gastroenterology. 2018 Jul; 24(28):3071-3089. doi: 10.3748/wjg.v24.i28.3071
Minalyan A, Gabrielyan L, Scott D, Jacobs J, Pisegna JR. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Current Gastroenterology Reports. 2017 Aug; 19(8):42. doi: 10.1007/s11894-017-0577-6
Ebrahimzadeh Attari V, Somi MH, Asghari Jafarabadi M, Ostadrahimi A, Moaddab SY, Lotfi N. The Gastro-protective Effect of Ginger (Zingiber officinale Roscoe) in Helicobacter pylori Positive Functional Dyspepsia. Advanced Pharmaceutical Bulletin. 2019 Jun; 9(2):321-324. doi: 10.15171/apb.2019.038
Prasad S and Tyagi AK. Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer. Gastroenterology Research and Practice. 2015; 2015:142979. doi: 10.1155/2015/142979
Khan WA and Alishah S. H. pylori Infection in human Gastrointestinal Cancer Diagnosis and Treatment Control: A review. International Journal of Advanced Research in Biological Sciences. 2022; 9(7):108-19. doi: 10.22192/ijarbs
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology. 2017 Feb; 112(2):212-239. doi: 10.1038/ajg.2016.563
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016 Jul; 151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006
Selgrad M and Malfertheiner P. New strategies for Helicobacter pylori eradication. Current Opinion in Pharmacology. 2008 Oct; 8(5):593-7. doi: 10.1016/j.coph.2008.04.010
Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007 Apr; 12(2):89-102. doi: 10.1111/j.1523-5378.2007.00478.x
de Vries R, Klok RM, Brouwers JR, Postma MJ. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health. Vaccine. 2009 Feb; 27(6):846-52. doi: 10.1016/j.vaccine.2008.11.081
Sutton P and Boag JM. Status of vaccine research and development for Helicobacter pylori. Vaccine. 2019 Nov; 37(50):7295-7299. doi: 10.1016/j.vaccine.2018.01.001
Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X. Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond. International Journal of Molecular Sciences. 2017 Aug; 18(8):1699. doi: 10.3390/ijms18081699
Burkitt MD, Duckworth CA, Williams JM, Pritchard DM. Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Disease Model and Mechanism. 2017 Feb; 10(2):89-104. doi: 10.1242/dmm.027649
Fortunato F, Bürgers H, Bergmann F, Rieger P, Büchler MW, Kroemer G, et al. Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology. 2009 Jul; 137(1):350-60, 360.e1-5. doi: 10.1053/j.gastro.2009.04.003
Li L and Yu C. Helicobacter pylori Infection following Endoscopic Resection of Early Gastric Cancer. Biomed Research International. 2019 Oct; 2019:9824964. doi: 10.1155/2019/9824964
Lamont JT. Patient education: Helicobacter pylori infection and treatment (Beyond the Basics).
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology. 2017 Feb; 112(2):212-239. doi: 10.1038/ajg.2016.563
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016 Jul; 151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006
Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 Jan; 66(1):6-30. doi: 10.1136/gutjnl-2016-312288
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiologic Reviews. 2000; 22(2):283-97. doi: 10.1093/oxfordjournals.epirev.a018040
Mégraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Alimentary Pharmacology and Therapeutics. 1995; 9 Suppl 2:85-91. PMID: 8547533.
Du Y, Zhu H, Liu J, Li J, Chang X, Zhou L, et al. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). Journal of Gastroenterology and Hepatology. 2020 Apr; 35(4):624-629. doi: 10.1111/jgh.14947
Bytzer P, Dahlerup JF, Eriksen JR, Jarbøl DE, Rosenstock S, Wildt S. Diagnosis and treatment of Helicobacter pylori infection. Danish Medical Bulletin. 2011 Apr; 58(4):C4271.
Ishaq S and Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterology and Hepatology from Bed to Bench. 2015 Spring; 8(Suppl 1):S6-S14
Díaz P, Valenzuela Valderrama M, Bravo J, Quest AFG. Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression. Frontiers in Microbiology. 2018 Jan; 9:5. doi: 10.3389/fmicb.2018.00005
Mentis AA, Boziki M, Grigoriadis N, Papavassiliou AG. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword. Cell and Molecular Life Sciences. 2019 Jul; 76(13):2477-2486. doi: 10.1007/s00018-019-03044-1
Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, et al. Family History of Gastric Cancer and Helicobacter pylori Treatment. The New England Journal of Medicine. 2020 Jan; 382(5):427-436. doi: 10.1056/NEJMoa1909666
Zhang XY, Zhang PY, Aboul-Soud MA. From inflammation to gastric cancer: Role of Helicobacter pylori. Oncology Letters. 2017 Feb; 13(2):543-548. doi: 10.3892/ol.2016.5506
Zhang W, Lu H, Graham DY. An Update on Helicobacter pylori as the Cause of Gastric Cancer. Gastrointestinal Tumors. 2014 Aug; 1(3):155-65. doi: 10.1159/000365310
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiologic Reviews. 2000; 22(2):283-97. doi: 10.1093/oxfordjournals.epirev.a018040
Ebrahimzadeh Attari V, Somi MH, Asghari Jafarabadi M, Ostadrahimi A, Moaddab SY, Lotfi N. The Gastro-protective Effect of Ginger (Zingiber officinale Roscoe) in Helicobacter pylori Positive Functional Dyspepsia. Advanced Pharmaceutical Bulletin. 2019 Jun; 9(2):321-324. doi: 10.15171/apb.2019.038
Goodman KJ and Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. International Journal of Epidemiology. 1995 Oct; 24(5):875-87. doi: 10.1093/ije/24.5.875
Li H, Yang T, Tang H, Tang X, Shen Y, Benghezal M, et al. Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed. Precision Clinical Medicine. 2019 Jun; 2(2):77-80. doi: 10.1093/pcmedi/pbz009
Prasad S and Tyagi AK. Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer. Gastroenterology Research and Practice. 2015; 2015:142979. doi: 10.1155/2015/142979
Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules. 2021 Oct; 26(19):6078. doi: 10.3390/molecules26196078
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments